tiprankstipranks
Trending News
More News >
Sangamo Biosciences (SGMO)
NASDAQ:SGMO
US Market

Sangamo Biosciences (SGMO) Income Statement

Compare
2,561 Followers

Sangamo Biosciences Income Statement

Last quarter (Q3 2025), Sangamo Biosciences's total revenue was $581.00K, a decrease of -98.82% from the same quarter last year. In Q3, Sangamo Biosciences's net income was $-34.93M. See Sangamo Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 57.80M$ 176.23M$ 111.30M$ 110.70M$ 118.19M
Gross Profit
$ 57.80M$ 176.23M$ 99.19M$ 110.70M$ -62.45M
Operating Expenses
$ 161.77M$ 450.24M$ 300.47M$ 294.04M$ 67.10M
Depreciation and Amortization
$ 9.36M$ 22.19M$ 12.11M$ 17.64M$ 5.68M
EBITDA
$ -89.09M$ -96.80M$ -189.17M$ -165.70M$ -123.87M
Operating Income
$ -103.97M$ -274.00M$ -201.28M$ -183.34M$ -129.55M
Other Income/Expenses
$ 5.86M$ 11.10M$ 9.43M$ 5.35M$ 8.77M
Pretax Income
$ -98.11M$ -262.90M$ -191.85M$ -177.99M$ -120.78M
Net Income
$ -97.94M$ -257.83M$ -192.28M$ -178.29M$ -121.00M
Per Share Metrics
Basic EPS
$ -0.49$ -1.48$ -1.25$ -1.23$ -0.90
Diluted EPS
$ -0.49$ -1.48$ -1.25$ -1.23$ -0.90
Weighted Average Shares Outstanding
201.70M 174.44M 154.34M 144.57M 134.45M
Weighted Average Shares Outstanding (Diluted)
201.70M 174.44M 154.34M 144.57M 134.45M
Currency in USD

Sangamo Biosciences Earnings and Revenue History